Rui Ren

· In 1999, graduated from Shandong Jinan Medical University, majoring in clinical

· 2000 - 2006, studied at European Intercollege and CTL European College. During study abroad,  participated in the first China-EU Tourism Annual Conference. Aslo, participated in the completing promotional documents for the Chinese Silk Flower Tourism Company in Europe, and participated in the completion of the first batch of Docking of domestic tour groups

· In 2006, directly established domestic direct business with ACM Warehousing Company in Greece. Served as the head of ACM in China at the same time.

· 2012 - 2018, cooperated with the largest Chinese chamber of commerce in Italy to introduce and promote domestic and foreign brands.

· 2018 - Present, Cooperated with Spanish Inmunotek S.L.  & German Doctor Fook to exclusively introduce foreign reagents into China.

· 2020 - Present. Successfully promoted and sold domestic new crown detection products, antibodies, antigens and PCR. Sales areas include Europe, the Middle East, Southeast Asia, Hong Kong and other regions.

Peiyan Zheng

· Associate Researcher, Guangzhou High-level Talent  

· Member of the Professional Committee of Pulmonary Allergy of Guangdong Association of Thoracic Disease  

· Member of the Professional Committee of Allergy Prevention and Control of Guangdong Preventive Medicine Association  

· Responsible for the platform construction and management of the National Center for Respiratory Medicine of Immunization Department  

· Has been engaged in the medical, teaching and research work of respiratory diagnostics  

· In 2021, won the first prize of Guangdong Preventive Medicine Association Science and Technology Award  

· Research Interests: Respiratory diagnostics  

· Presided one National Natural Science Project and participated in 5 National Natural Science Projects, presided over 8 provincial and municipal projects, published 28 SCI papers in Cellular and Molecular Life Sciences, Pediatric Allergy and Immunology, Allergy

Jun Li

· Graduated from Tokyo Medical University, Japan，majoring in Paediatric endocrinology/pathology  

· Former  Business development director of Winhealth Pharma.     Setting up collaboration with Tokyo University for R&D   Former Senior Business Manager of  Techpool.    Successfully introduced Wako liver cancer screening reagent and equipment  

· Former Business Development Manager of Eisai Asia Business Strategy Dept.    

· Familiar with the pharmaceutical market and policies in China and other Asian countries  

· Former BrandManager of anti-hematoblastic drugs at Mitsubishi Pharmaceutical Company,    responsible for Anplag and Novastan  

· Former Academic Representative/Assistant of Marketing Director of Sankyo Pharmaceutical Company  

· Former Paediatrician of Shanghai Longhua hospital

Jiasheng Fu  Chief Technical Advisor

Dr.Fu graduated from University of Alberta in Canada. He was a senior scientist of Amgen in the United States. He has more than 20 years of experience in chemical synthesis and drug molecular screening. He has developed 3 small molecule drugs that have been in clinical research stage.

Huang Mingtao  Scientific Advisor

Professor Huang, doctoral tutor, the entrant of National Talent Plan Youth Program. He received his BS and PhD degrees from Sun Yat-Sen University in 2006 and 2011, respectively.Then, he did postdoctoral research at Chalmers University of Technology, Sweden. In 2019, he joined the School of Food Science and Engineering in South China University of Technology. In recent years,  Professor Huang took the model organism Saccharomyces cerevisiae as the research object, successfully applied the microfluidic high-throughput screening platform to the sorting of high-amylase-secreting yeast strains, and analyzed the internal nutrient metabolism regulation mechanism and protein secretion pathway of yeast.He completed the rational design and construction of recombinant amylase high-secreting yeast strains, and promoted the integration and application of cutting-edge technologies such as microfluidics, systems and synthetic biology. He has published many papers in internationally renowned journals such as PNAS, Nature Comm., and Cell, and his research results have been reported by many scientific and technological media. He has participated in many international academic conferences to demonstrate research progress, and has been invited as a reviewer for well-known professional journals such as Metab. Eng., ACS Synth. Bio., Biotech. & Bioeng., Biotech. Biofuel.

Li Lei  Technical consultant

Associate Professor, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology; Bachelor of Microbiology, Sun Yat-Sen University; Ph.D., State Key Laboratory of Virology in Wuhan University. From 2011 to 2013, she was sponsored by the China Scholarship Council as a visiting scholar at the UCSF School of Pharmacy in the United States. Main research directions and achievements: ① Focus on the pathogenesis of liver cancer, and explore the main signaling pathways and targets involved in the occurrence and development of liver cancer by means of molecular biology and cell biology; ② She is the first person in China to create a new transgenic mouse model of orthotopic liver cancer, and the relevant research results were published in the Journal of Hepatology and Hepatology, the authoritative journals of hepatology as the corresponding author or the first author; ③Drug evaluation; ④Product development and industrialization for innovative nucleic acid detection systems. Recently published paper as first author or corresponding author: Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression Hepatology. First published: 27 March 2022 https://doi.org/10.1002/hep.32483 (IF 17.425) (and was selected by the magazine as the cover story of the November 2022 issue)

………………